From bench to bedside – A mission for a healthy life

From bench to bedside – A mission for a healthy life

The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.

32. Jahrestagung der Deutschen Gesellschaft für Zytometrie
hybrid
28. - 30. September 2022, Industry-Webinare at 26. & 27. September 2022
Zahl des Monats
Diese und weitere Zahlen finden Sie in der Kerndokumentation

News

Science at DRFZ

Sign up for the DRFZ NewsFlash